Ferguson James J. III

Ferguson James J. III is listed in filings as Chief Medical Officer at Cadrenal Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Feb 6, 2025, including 1 public disclosure. Recent filings connect the profile to Cadrenal Therapeutics, Inc. Common Stock (CVKD). The current snapshot covers public activity from Feb 6, 2025. Reported amounts are shown as $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.